SCYNEXIS
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell SCYNEXIS and other ETFs, options, and stocks.About SCYX
SCYNEXIS, Inc. is a biotechnology company, which engages in the development of novel oral and intravenous triterpenoid antifungal for the treatment of several fungal infections, including vulvovaginal candidiasis, invasive aspergillosis, invasive candidiasis, and refractory invasive fungal infections. The company was founded by Scot Kevin Huber, Terry Eugene Marquardt, Pierre Bernard Jacques Monnet, Russell J.
SCYX Key Statistics
Stock Snapshot
As of today, SCYNEXIS(SCYX) shares are valued at $0.77. The company's market cap stands at 32.67M, with a P/E ratio of -1.45.
During the trading day, SCYNEXIS(SCYX) stock saw an opening price of $0.79, a peak of —, and a bottom of —.
Trading volume for SCYNEXIS(SCYX) stock has reached 0, versus its average volume of 353K.
The stock's 52-week range extends from a low of $0.57 to a high of $1.31.
The stock's 52-week range extends from a low of $0.57 to a high of $1.31.
People also own
Similar Marketcap
This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.
Popular Stocks
This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset
Newly Listed
This list is generated by showing companies that recently went public.